Clear Wave Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Sell
2,023
-1,091
-35% -$164K 0.06% 132
2026
Q1
$476K Buy
+3,114
New +$477K 0.1% 88

Other funds holding NVS

Clear Wave Wealth Management's NVS Position: Q2 2026 in Review

Clear Wave Wealth Management reduced its Novartis (NVS) stake by 35% in Q2 2026, selling an estimated $164K and leaving 2,023 shares worth $317K. The position accounts for 0.06% of the portfolio, ranked #132.

Clear Wave Wealth Management first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $476K in Q1 2026. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Clear Wave Wealth Management held 2,023 shares of Novartis worth $317K as of Q2 2026.
  • Clear Wave Wealth Management sold 1,091 Novartis shares in Q2 2026, an estimated $164K.
  • Novartis made up 0.06% of Clear Wave Wealth Management's portfolio in Q2 2026, its #132 holding.
  • Clear Wave Wealth Management first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • Clear Wave Wealth Management's Novartis position peaked at $476K in Q1 2026.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Clear Wave Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.